SBIR-STTR Award

Rhesus Monkey IGG Subtyping Reagents
Award last edited on: 3/5/07

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$763,123
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Berge Hampar

Company Information

Bio Molecular Technology Inc (AKA: BMT~BioMolecular Technology Inc)

5340 Spectrum Drive
Frederick, MD 21701
   (301) 831-4068
   bmt1@bmtinc.com
   www.bmtinc.com
Location: Single
Congr. District: 06
County: Frederick

Phase I

Contract Number: 1R44AI045243-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1999
Phase I Amount
$82,761
AIDS research has been impeded somewhat by the lack of a suitable animal model for study the pathology of HIV and for testing potential therapeutic and vaccine reagents. As a result, alternative virus models are being studied, such as SIV and SHIV, which express many of the properties characteristic of HIV an can cause a disease in rhesus monkeys comparable to AIDS. The availability of additional reagents for studying the immune response of rhesus monkeys to virus infection can significantly add to the armamentarium of AIDS researchers. One such class of reagents not currently available includes Mabs to rhesus monkey IgG subclasses, which can be employed for immuno-phenotyping. We have developed a mouse Mab (1S) which expresses properties characteristic of a rhesus monkey subclass-specific antibody. The aims of this Phase 1 proposal are to confirm the specificity of the 1sMab and to initiate studies for generating additional rhesus monkey subclass-specific Mabs. PROPOSED COMMERCIAL APPLICATION: Not Available

Thesaurus Terms:
immunoglobulin G, immunologic assay /test, serology /serodiagnosis, technology /technique development diagnosis design /evaluation, enzyme linked immunosorbent assay, fluorimetry, immunoglobulin structure, monoclonal antibody, reagent /indicator Macaca mulatta

Phase II

Contract Number: 4R44AI045243-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2000
(last award dollars: 2001)
Phase II Amount
$680,362

AIDS research has been impeded somewhat by the lack of a suitable animal model for study the pathology of HIV and for testing potential therapeutic and vaccine reagents. As a result, alternative virus models are being studied, such as SIV and SHIV, which express many of the properties characteristic of HIV an can cause a disease in rhesus monkeys comparable to AIDS. The availability of additional reagents for studying the immune response of rhesus monkeys to virus infection can significantly add to the armamentarium of AIDS researchers. One such class of reagents not currently available includes Mabs to rhesus monkey IgG subclasses, which can be employed for immuno-phenotyping. We have developed a mouse Mab (1S) which expresses properties characteristic of a rhesus monkey subclass-specific antibody. The aims of this Phase 1 proposal are to confirm the specificity of the 1sMab and to initiate studies for generating additional rhesus monkey subclass-specific Mabs.

Thesaurus Terms:
immunoglobulin G, immunologic assay /test, serology /serodiagnosis, technology /technique development diagnosis design /evaluation, enzyme linked immunosorbent assay, fluorimetry, immunoglobulin structure, monoclonal antibody, reagent /indicator Macaca mulatta